cso f p 106 articl heinz dieterich steffan f text havana becom remain one first class nation say konrad seitz director strateg plan depart german ministri foreign affair one rout master one five key technolog futur world market comput biotechnolog space technolog new form energi new materi technolog import say noam chomski biotechnolog opinion german strategist ad second condit admiss perman membership first world independ state suffici autonomi polit determin deal major world power center defend develop project base nation interest light paramet futur latin american countri appear dismal except costa rica repres latin america cuba countri meet two requisit therefor one good probabl leav underdevelop behind real independ cuban state requir demonstr five technolog futur cuba one world leader unit state one import biotechnolog genet engin year 2000 market volum 200 billion cuba domin larg part follow report present summari numer interview director cuban biomed biotechnolog institut provid extens account yet publish abroad spectacular advanc made cuban biotechnolog school lack inform due cuban clamp flow inform instead virtual censorship report success cuban process censorship prevail almost western commun media h5 aid vaccin h5 laboratori world cuba also intens work scourg aid accord world health organ estim date afflict 12 million peopl mani countri one lead caus death mexico fourth place 1991 cuban biotechnolog school battl aid wage three front develop vaccin viru design accur inexpens diagnost system massiv use blood bank popul develop medic treat opportunist infect diseas occur aid induc weaken immun system cigb genet engin biotechnolog center one import center work develop aid vaccin 62 000 squar meter facil near havana 600 scientist young produc 160 differ product 30 develop genet engin scientif staff expertis modern methodolog necessari includ genet engin molecular biolog immunolog advanc biochemistri advanc research product hardwar world reveal inspect tour lab industri facil dr manuel limonta director institut scientif board state cuba aid vaccin 2000 earlier say work group develop vaccin aid use genet engin technolog prevent diseas strong group alreadi work program long period time group produc signific result limonta describ signific result sourc deduc manag isol character specif viral strain respons hiv laboratori test phase cigb director express confid manag bring aid control immunolog state categor go develop vaccin dieterich steffan french american limonta know happen believ may 2000 person belief think may earlier may around time view matter dr limonta make pronounc might appear somewhat rash limonta heavyweight field person achiev institut direct lend author assert support director cnic nation center scientif research dr carlo gutierrez say limonta team practic live lab tri solv someth extraordinarili dedic work make statement capabl recal achiev interferon exampl limonta work small team young research propos produc interferon cuba peopl talk minimum time frame three four year 42 day truli record time everyon recogn lengthi list success cigb director mani achiev close collabor cuban scientif institut nearli 160 differ product develop cigb includ 30 produc genet engin start finish recombin product convey idea mean dr limonta explain known third world cuba countri develop start finish product use genet engin known regist product export product develop countri even countri much larger cuba like china india 1993 u patent trademark offic washington regist three patent cigb recogn origin product cuba countri technolog methodolog produc also recogn qualiti product meet food drug administr standard stringent world grant cuba exclus right produc sell product u territori 17 year product includ prevent medic myocardi infarct call estreptoquinasa regist 07 703 778 first vaccin mening bc develop anywher world 07 754 918 invertas sucros enzym convert sugar fructos estreptoquinasa cuba except one u firm countri produc medic say limonta explain product dissolv clot coronari arteri medicin capabl elimin clot high percentag patient administ immedi infarct prevent infarct progress act prevent myocardi infarct patent registr product alreadi appli 40 countri go grant know one develop origin process make medic get patent type reflect high technolog capabl institut case technolog genet engin studi drug produc unit state demonstr biolog effect similar cuban product howev cuban medic much cheaper u drug estreptoquinasa also develop record time time idea first conceiv product regist medic four year elaps averag cuba product develop less time u japanes compani studi done u japanes scientist say 1 3 time product term time requir complet product put use compli legal requir practic higher product coeffici may mean exampl u japanes product requir 10 year research product may develop seven year cuba explan offer cuban scientist surpris phenomenon complex agre educ scientif philosophi revolut young peopl result key factor anoth spectacular success cigb known nerv growth factor still known elsewher world say limonta nobodi els abl develop medic protein use regener nervou system damag could also use diseas like alzheim product enter industri product phase enabl use clinic trial h5 genet alter anim plant h5 anoth line research cigb pursu genet modif anim plant date produc transgen mice rabbit fish goal produc genet alter cow limonta explain anim new trait genet inform introduc fertil ovum anim assimil transmit hereditarili way genet chang produc new speci even creat specif object make mammal milk case cow milk also produc medic cow excel milk produc laboratori introduc laboratori intellig enabl addit milk also produc specif protein could exampl interferon product cow seem quit simpl would need complex costli industri interferon product process requir use ferment equip close monitor etc entir process would done sole anim would extract product milk milk would use normal dieterich steffan sound like scienc fiction limonta ye go happen absolut sure alreadi done obtain medic rabbit milk dieterich steffan intern specialist know limonta one read intern public first mice test methodolog use rabbit improv methodolog produc medic success work produc medic larger anim cow done yet go h5 growth hormon h5 manuel limonta also discuss cigb progress control use growth hormon work fish area realli one advanc group world introduc genet inform contain growth hormon fish caus fish grow rapidli reach larger size normal quickli incorpor food better time save half even larger percentag compar normal growth period fish case tilapia carp still reproduc larg quantiti fundament step taken field anim health creat first time anywher world vaccin cattl tick patent regist brazil argentina mexico countri develop vaccin porcin colibacillosi diseas whose mortal rate among newborn pig 100 percent anoth notabl scientif achiev present time advanc version vaccin develop area plant health use biotechnolog result increas plant resist specif pest transgen tobacco produc resist manduca septa moth insect destroy tobacco leaf genet modif moth kill without damag leaf accomplish without alter plant characterist potato resist one three type viru affect seed anoth cigb achiev work develop resist two also produc genet alter cabbag moth resist gene also develop transgen sugarcan first time world genet alter sugarcan develop sugarcan resist pest h5 achiev h5 one cigb big achiev recombin vaccin hepat b use 20 countri cuba given newborn part nationwid program anoth complet new product regist cuba countri still avail market skin growth factor use treat burn import product includ human monoclin antibodi treatment industri area new enzym one enzym invertas sucros transform sugar fructos fructos use sweeten improv flavor amount sugar need reduc 20 30 percent method technolog use industri applic exclus cuban h5 aid h5 second front aid diagnosi cuba three differ techniqu first develop aid research laboratori second cigb third cie immunoassay center discuss cigb techniqu dr limonta comment uniqu diagnost method develop exampl aubio system drop blood deposit plastic strip react seri genet engin compon deposit plastic strip structur similar protein compon viru membran plu gold base dye drop blood come contact plastic strip chang color produc indic simpli sight whether person infect system also develop use diagnos toxoplasmosi hepat c etc use expand ill offer advantag requir special equip mix blood read result even requir technician electr current result visibl ordinari natur light differ method develop cie substanti improv classic method immunodiagnosi reduc amount blood sampl reagent 10 percent efficaci diagnost method ultra micro elisa hiv demonstr mani countri well intern evalu aid refer center affili world health organ paho pan american health organ exampl brazil canada also cuba cie market aid diagnost kit mani countri anyon buy drugstor kit contain paper filter pipett extract blood sampl finger form blood sampl allow dri filter person select anonym person code list form exampl abc 345 send dri blood sampl laboratori autom reader like cuban suma read test determin margin accuraci virtual 100 percent whether person hiv posit person later call laboratori give anonym person code receiv result absolut confidenti privaci system use mani countri includ spain use approv ministri health consum affair market price averag 20 30 percent less price product cie provid technic personnel technic analyt instrument assist need conveni say cie director qualiti control dr rene robaina institut like blood bank need assist provid complet attent includ everyth lab setup personnel train later assist anoth advantag person aid diagnosi regist intern name hipertest paper filter contain blood sampl sent mail messeng highli stabl dri last month without accuraci diagnosi alter hipertest sold mexico could done perfectli well simpli find transfer mechan say robaina similar exampl form joint capit ventur russia brazil colombia spain china ghana etc test produc exclus immunoassay center filter paper must extrem homogen qualiti import germani chemic reagent also come world market biolog reagent mostli produc cuba technolog exclus cuban cnic medicin develop diseas occur weaken immunolog defens caus aid work medic allevi aid still cannot cure say dr carlo gutierrez tri get rid diseas know medic slightli lengthen live patient tri investig possibl combin medic advanc level laboratori test laboratori go bench test pilot plant final industri plant bench test stage produc medic could extend patient live h5 vaccin h5 finlay institut area 23 000 squar meter unequal latin america one modern world 650 employe develop world first vaccin mening 1990 award gold model unit nation world intellectu properti organ achiev vaccin develop bare five year research work live microorgan creat high risk infect vaccin took possibl hygien precaut explain dr concepcion carma director institut coordin research group develop vaccin work larg volum bacteria talk kilogram live bacteria grown larg 300 liter ferment vat real risk first volunt use vaccin research matter ethic polici believ could put could ask anyon els tri test vaccin children appli ethic standard children first one use vaccin later go field test explain doctor vaccin use number latin american countri argentina chile colombia etc mening preval brazil 20 million dose administ without sever advers reaction report cuban trial vaccin demonstr efficaci 83 98 percent anoth import line research anticholera vaccin alreadi undergon laboratori test import result anim test complet three phase trial human be begin follow field test done latin american countri cuba countri hemispher cholera exist h5 myocardi infarct h5 entri cnic havana visitor read statement fidel castro futur nation necessarili belong men scienc institut leader promot cuban biotechnolog quotat becom realiti major achiev attest among ppg policosanol combat one princip risk factor infarct high cholesterol level ppg began market august 1991 develop compon found sugarcan whose solut properti reduc certain type cholesterol time 200 000 cuban use ppg regularli result posit term patient physic psycholog even sexual reaction medic approv use 12 countri patent applic pend 22 countri pill cost 1 minimum recommend dosag one tablet day product whose action similar ppg estatina mean unknown 1 5 two time expens also tri extract sugarcan raw materi produc phytosteroid order manufactur steroid hormon basic element anticontracept pill cnic develop new product beyond laboratori stage includ test anim pilot plant level anoth island natur resourc use biomedicin biotechnolog cuba coral reef sinc cuban revolut care nation ecolog coral practic free pollut dr gutierrez feel coral human medicin better synthet materi synthet materi introduc molecul may detriment human organ least secondari aspect natur materi outperform artifici materi scientif studi reveal certain speci coral materi use transplant graft due great biocompat human bone tissu ideal architectur porou structur tridimension interconnect physico mechan biochem properti calcium phosphat h5 ozon therapi h5 treatment develop cnic uniqu world use ozon therapi treat retin pigmentosa left untreat lead blind use ozon therapi advanc diseas halt patient sight improv see patient two year say dr gutierrez gotten wors improv done anywher els world origin equip convert oxygen ozon import cuban develop innov applic ozon therapeut industri use cimeq medic surgic research center ozon therapi use dissolv compon blood clot five year anim experi treatment appli human be coronari cerebr diseas techniqu still experiment stage use arteri obstruct lower extrem altern dilat laser treatment result present intern confer vienna pari brazil uruguay anoth import line research cnic pursu use monoclin antibodi diagnos plant diseas exampl product diagnos tristeza babesia viru attack citru crop diseas exist cuba purchas citru fruit requir proof fruit diseas use diagnost tool easi demonstr h5 medic equip h5 diagnos clinic neurophysiolog central nervou system computer equip develop like neuronica medicid neuronica use measur visual auditori percept brain wave sleep medicid use analyz nervou system cerebr function cerebr map exampl provid computer readout electroencephalogram eeg display result monitor due u embargo cuban produc comput program equip use mexico diram anoth computer devic provid rapid microbiolog diagnosi four hour determin reliabl type infect pattern sensit antibiot antibiogram diagnosi requir 72 hour convent method use indic effect antibiot specif infect avoid develop bacteri resist ineffect use antibiot fatal outcom seriou infect short analysi time small volum requir low cost possibl corrobor result often may desir anoth advantag system use sampl isol purifi strain bacteria also direct specimen blood urin cultur first world countri equip similar function exist four five time expens diram faster cheaper cuba abl export cie develop suma ultramocroanalyt system low cost analysi laboratori sampl primarili use diagnosi infecti diseas blood bank epidemiolog variou health program suma result 18 year research cie havana produc equip suma laboratori europ asia africa latin america equip use detect aid hepat b meningococcu alphafetoprotein etc cuba suma use prenat diagnosi virtual pregnant women detect congenit malform like neural tube defect hypothyroid h5 dengu cholera h5 pedro kouri tropic medicin institut respons protect cuban popul epidem infecti diseas kept infecti diseas africa spread cuba despit return home ten thousand cuban soldier highli effici diagnost tool develop diagnost system dengu fever use mani latin american countri report dr alina llop rapid detect diagnost kit antibodi sold commerci kit uniqu intern market similar kit develop detect streptococcu group b provid result three hour addit analys mening infect cholera convent method take less four day obtain eight hour new cuban molecular biolog diagnost system cuba probabl countri latin america system anoth system great import third world new diagnost tool amebiasi base molecular biolog 100 percent accuraci rate obvious elimin uncertainti inher convent method also biomed bioscientif area exampl develop comput medic imag cuba one world leader h5 young scientist h5 key factor explain wide held opinion director interview spectacular advanc cuban biotechnolog school prioriti given sinc 1959 educ public health thank critic mass young scientist high qualiti creativ disciplin human factor actual element differenti cuban biotechnolog school advanc laboratori unit state europ japan high tech laboratori use technolog equip explain visitor enter technolog facil cuban research product center find type swiss bioreactor huge japanes electron microscop german tomograph equip french mass spectromet first world counterpart thing true chemic biolog raw materi produc cuba polit determin cuban state effici network cooper research product institut unusu combin basic appli research well strong insist product must meet intern standard qualiti factor contribut success u embargo cuban scientif institut necessarili work european japanes multin u corpor remain outsid commerci develop enorm cuban potenti howev probabl u busi elit toler exclus much longer instead probabl opt vietnam cooper cuban biotechnolog raison etr put end embargo cuba continu emerg isol throughout latin america europ reconcili miami exil extraordinari intern reform lead direct cohes cuban model resist next two three year cuba becom except costa rica latin american nation project solid foundat enabl leav underdevelop behind emerg backyard unit state review medic aspect report wish thank dr lui felip bojalil j distinguish professor metropolitan xochimilco autonom univers recipi scienc award academi scientif research